Ask AI
ASC2ESCALATE
ASC2ESCALATE: Phase II Trial of Asciminib in Patients With CML-CP After 1 TKI

Released: June 02, 2025

Expiration: December 01, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 02, 2025

Expiration: December 01, 2025